1887

Journal of Medical Microbiology logo

Volume 55, Issue 3

Natural resistance, iron and infection: a challenge for clinical medicine Free

Abstract

Natural resistance to infection, which does not depend on antibiotics, is a powerful protective mechanism common to all mankind that has been responsible for the survival of our species during countless millennia in the past. The normal functioning of this complex system of phagocytic cells and tissue fluids is entirely dependent on an extremely low level of free ionic iron (10 M) in tissue fluids. This low-iron environment is maintained by the unsaturated iron-binding proteins transferrin and lactoferrin, which depend on well-oxygenated tissues, where a relatively high oxidation–reduction potential (Eh) and pH are essential for the binding of ferric iron. Freely available iron is derived from iron overload, free haem compounds, or hypoxia in injured tissue leading to a fall in Eh and pH. This can severely damage or abolish normal bactericidal mechanisms in tissue fluids leading to overwhelming growth of bacteria or fungi. The challenge for clinical medicine is to reduce or eliminate the presence of freely available iron in clinical disease. In injured or hypoxic tissue, treatment with hyperbaric oxygen might prove very useful by increasing tissue oxygenation and restoring normal bactericidal mechanisms in tissue fluids, which would be of huge benefit to the patient.

  • Published Online:
SGM
Loading

Article metrics loading...

/content/journal/jmm/10.1099/jmm.0.46386-0
2006-03-01
2024-04-19
Loading full text...

Full text loading...

/deliver/fulltext/jmm/55/3/251.html?itemId=/content/journal/jmm/10.1099/jmm.0.46386-0&mimeType=html&fmt=ahah

References

  1. Agarwal N., Murphy J. G., Cayten C. G., Stahl W. M. 1993; Blood transfusion increases the risk of infection after trauma. Arch Surg 128:171–176 [CrossRef]
     [Google Scholar]
  2. Anuwatanakulchai M., Pootrakul P., Thuvasethakul P. 1984; Non transferrin iron in B-thalassaemia/ Hb E and haemoglobin H diseases. Scand J Haematol 32:153–158
     [Google Scholar]
  3. Artis W. M., Fountain J. A., Delcher H. K., Jones H. E. 1982; A mechanism of susceptibility to mucormycosis in diabetic ketoacidosis: transferrin and iron availability. Diabetes 31:1109–1114 [CrossRef]
     [Google Scholar]
  4. Blake P. A., Merson M. H., Weaver R. E., Hollis D. G., Heublein P. C. 1979; Disease caused by a marine vibrio. Clinical characteristics and epidemiology. . N Engl J Med 300:1–5 [CrossRef]
     [Google Scholar]
  5. Boelaert J. R., de Locht M., van Cutsem J., Kerrels V., Cantinieaux B., Verdonck A., van Landuyt H. W., Schneider Y.-J. 1993; Mucormycosis during deferoxamine therapy is a siderophore mediated infection: in - vitro and in - vivo animal studies. J Clin Invest 91:1979–1986 [CrossRef]
     [Google Scholar]
  6. Bonsdorf L., von Sahlstedt L., Ebeling F., Ruutu T., Parkkinen J. 2003; Apotransferrin administration prevents growth of Staphylococcus epidermidis in serum of stemcell transplant patients by binding of free iron. FEMS Immunol Med Microbiol 37:45–51 [CrossRef]
     [Google Scholar]
  7. Bullen J. J., Griffiths E. 1999; Iron binding proteins and host defence. In Iron and Infection. Molecular, Physiological and Clinical Aspects , 2nd edn. pp  327–368 Edited by Bullen J. J., Griffiths E. Chichester: Wiley;
     [Google Scholar]
  8. Bullen J. J., Dobson A., Wilson A. B. 1964; Bacteriostatic effects of specific antiserum on C lostridium welchii type A. The role of Eh and pH of the medium. . J Gen Microbiol 35:175–182 [CrossRef]
     [Google Scholar]
  9. Bullen J. J., Cushnie G. H., Rogers H. J. 1967; Abolition of the protective effect of Clostridium welchii type A antiserum by ferric iron. Immunology 12:303–312
     [Google Scholar]
  10. Bullen J. J., Cushnie G. H., Stoner H. B. 1966; Oxygen uptake by Clostridium welchii type A, its possible role in experimental infections in passively immunised animals. Br J Exp Pathol 47:488–506
     [Google Scholar]
  11. Bullen J. J., Leigh L. C., Rogers H. J. 1968a; The effect of iron compounds on the virulence of Escherichia coli for guinea pigs. Immunology 15:581–588
     [Google Scholar]
  12. Bullen J. J., Wilson A. B., Cushnie G. H., Rogers H. J. 1968b; The abolition of the protective effect of Pasteurella septica antiserum by iron compounds. Immunology 14:889–898
     [Google Scholar]
  13. Bullen J. J., Rogers H. J., Griffiths E. 1978; Role of iron in bacterial infection. Curr Top Microbiol Immunol 80:1–35
     [Google Scholar]
  14. Bullen J. J., Spalding P. B., Ward C. G., Gutteridge J. M. C. 1991; Haemochromatosis, iron, and septicaemia caused by Vibrio vulnificus . Arch Intern Med 151:1606–1609 [CrossRef]
     [Google Scholar]
  15. Bullen J. J., Spalding P. B., Ward C. G., Rogers H. J. 1992; The role of Eh, pH, and iron in the bactericidal power of human plasma. FEMS Microbiol Lett 94:47–52 [CrossRef]
     [Google Scholar]
  16. Bullen J. J., Rogers H. J., Spalding P. B., Ward C. G. 2005; Iron and infection, the heart of the matter. FEMS Immunol Med Microbiol 43:325–330 [CrossRef]
     [Google Scholar]
  17. Caroline L., Rosner F., Kozinn P. J. 1969; Elevated serum iron, low unbound transferrin and candidiasis in acute leukaemia. Blood 34:441–451
     [Google Scholar]
  18. Chart H., Griffiths E. 1985; The availability of iron and the growth of Vibrio vulnificus in sera from patients with haemochromatosis. FEMS Microbiol Lett 26:227–231 [CrossRef]
     [Google Scholar]
  19. Dale D. C. 2002; Colony-stimulating factors for the management of neutropenia in cancer patients. Drugs 62:1–15
     [Google Scholar]
  20. Eraklis A. J., Brammer S. R., Diamond L. K., Gross R. E. 1967; Hazard of overwhelming infection after splenectomy in childhood. N Engl J Med 267:1225–1229
     [Google Scholar]
  21. Evans D. G., Miles A. A., Niven J. S. F. 1947; The enhancement of bacterial infections by adrenaline. Br J Exp Pathol 29:20–39
     [Google Scholar]
  22. Evans R. W., Crawley J. B., Joannou C. L., Sharma N. D. 1999; Iron proteins. In Iron and Infection. Molecular, Physiological, and Clinical Aspects , 2nd edn. pp  27–86 Edited by Bullen J. J., Griffiths E. Chichester: Wiley;
     [Google Scholar]
  23. Gordeuk V. R., Brittenham G. M., McLaren G. D., Spagnuolo P. J. 1986; Hyperferraemia in immunosuppressed patients with acute nonlymphatic leukemia and the risk of infection. J Lab Clin Med 108:466–472
     [Google Scholar]
  24. Gottrup F. 2004; Oxygen in wound healing and infection. World J Surg 28:312–315 [CrossRef]
     [Google Scholar]
  25. Grief R., Akca O., Horn E.-P., Sessler D. I. 2000; Supplemental perioperative oxygen to reduce the incidence of surgical wound infection. N Engl J Med 342:161–167 [CrossRef]
     [Google Scholar]
  26. Griffiths E., Williams P. 1999; The iron-uptake systems of pathogenic bacteria, fungi and protozoa. In Iron and Infection. Molecular, Physiological, and Clinical Aspects , 2nd edn. pp  87–212 Edited by Bullen J. J., Griffiths E. Chichester: Wiley;
     [Google Scholar]
  27. Griffiths E., Cortes A., Gilbert N., Stevenson P., MacDonald S., Pepper D. 1995; Haemoglobin-based blood substitutes and sepsis. Lancet 345:158–160 [CrossRef]
     [Google Scholar]
  28. Groll A. H., Walsh T. J. 2003; Invasive fungal infections in the neutropenic cancer patient. Abstr Hematol Oncol 6:18–26
     [Google Scholar]
  29. Gutteridge J. M. C., Rowley D. A., Griffiths E., Halliwell B. 1985; Low-molecular-weight complexes and oxygen radical reactions in idiopathic haemochromatosis. Clin Sci 68:463–467
     [Google Scholar]
  30. Halliwell B., Aruoma O. I., Mufti G., Bomford A. 1988; Bleomycin detectable iron in serum from leukaemic patients before and after chemotherapy. FEBS Lett 241:202–204 [CrossRef]
     [Google Scholar]
  31. Henry J., Goodman J., Meehan J., Frankel R. 1947; Capillary permeability in relation to acute anoxia and to venous oxygen saturation. J Clin Invest 26:1119–1129 [CrossRef]
     [Google Scholar]
  32. Hershko C., Peto T. E. A., Weatherall D. J. 1988; Iron and infection. BMJ 296:660–664 [CrossRef]
     [Google Scholar]
  33. Hewitt L. F. 1950; Oxidation–reduction Potentials in Bacteriology and Biochemistry . , 6th edn. pp  97–127 Edinburgh: E&S Livingstone;
  34. Holdsworth R. J., Irving A. D., Cuschieri A. 1991; Postsplenectomy sepsis and its mortality rate: actual versus perceived risks. Br J Surg 78:1031–1038 [CrossRef]
     [Google Scholar]
  35. Hopf H. W., Hunt T. K., West J. M. & 9 other authors; 1997; Wound tissue oxygen tension predicts the risk of wound infection in surgical patients. Arch Surg 132:977–1004 [CrossRef]
     [Google Scholar]
  36. Karp J. E., Metz W. G. 1986; Association of reduced total iron binding capacity and fungal infections in leukemic granulocytopenic patients. J Clin Oncol 4:216–220
     [Google Scholar]
  37. King R. D., Kahn H. A., Foye J. C., Greenberg J. H., Jones H. E. 1975; Transferrin, iron and dermatophytes. 1. Serum dermatophyte inhibitory component definitively identified as unsaturated transferrin. J Lab Clin Med 86:204–212
     [Google Scholar]
  38. Lebovitz H. E. 1995; Diabetic ketoacidosis. Lancet 345:767–772 [CrossRef]
     [Google Scholar]
  39. Lestas A. N. 1976; The effect of pH on human transferrin, selective labelling of the two iron-binding sites. Br J Haematol 32:341–350 [CrossRef]
     [Google Scholar]
  40. Levere R. D., Swerdlow F., Garaway M. R. 1979; Measurement of human plasma haemoglobin by difference spectrophotometry. J Lab Clin Med 77:168–176
     [Google Scholar]
  41. Lieschke G. J., Burgess A. W. 1992; Granulocyte colony stimulating factor and granulocyte-macrophage colony-stimulating factor. N Engl J Med 327:28–35 [CrossRef]
     [Google Scholar]
  42. MacLennan J. D., MacFarlane R. W. 1945; Toxin and antitoxin studies of gas gangrene in man. Lancet 2:62–66
     [Google Scholar]
  43. Mandell G. I. 1974; Bactericidal activity of aerobic and anaerobic polymorphonuclear neutrophils. Infect Immun 9:337–341
     [Google Scholar]
  44. Marwah S. S., Blann A., Harrison P., Lumley M. A., Wright J., McDowell J., Phillips J. D., Rea C., Bareford D. 2002; Increased non-transferrin bound iron in plasma-depleted SAG-M red blood cell units. Vox Sang 82:122–126 [CrossRef]
     [Google Scholar]
  45. McLaren G. D., Muir W. A., Kellermeyer R. W. 1983; Iron overload disorders, natural history, pathogenesis, and therapy. Crit Rev Clin Lab Sci 19:205–266 [CrossRef]
     [Google Scholar]
  46. Murray B. E. 2000; Vancomycin resistant enterococcal infections. N Engl J Med 342:710–721 [CrossRef]
     [Google Scholar]
  47. National Institute of Allergy & Infectious Diseases; 2004; Fact Sheet: The Problem of Antibiotic Resistance . http://www.niaid.nih.gov/factsheets/antimicro.htm
  48. Oakley C. L. 1954; Gas gangrene. Br Med Bull 10:52–58
     [Google Scholar]
  49. Pootrakul P., Rugkiatsakul R., Wasi P. 1980; Increased transferrin saturation in splenectomised thalassemic patients. Br J Haematol 46:143–145
     [Google Scholar]
  50. Ramanan N., Wang Y. 2000; A high affinity iron permease essential for Candida albicans virulence. Science 288:1062–1064 [CrossRef]
     [Google Scholar]
  51. Rogers H. J. 1967; Bacteriostatic effects of horse sera and serum fractions on Clostridium welchii type A, and the abolition of bacteriostasis by iron salts. Immunology 12:285–301
     [Google Scholar]
  52. Shorr A. F., Duh M.-S., Kelly K. M., Kolief M. H. 2004; Red blood cell transfusion and ventillator-associated pneumonia, a potential link?. Crit Care Med 32:666–674 [CrossRef]
     [Google Scholar]
  53. Simmen H.-P., Blaser J. 1993; Analysis of pH and pO2 in abscesses, peritoneal fluid, and drainage fluid in the presence or absence of bacterial infection during and after abdominal surgery. Am J Surg 163:24–27
     [Google Scholar]
  54. Singer D. B. 1973; Postsplenectomy sepsis. Perspect Pediatr Pathol 1:285–311
     [Google Scholar]
  55. Sloan E. P., Koenigsberg M., Gens D., Cipolle M., Runge J., Mallory M. N., Rodman G. Jr 1999; Diaspirin cross-linked hemoglobin (DCLHb) in the treatment of severe haemorragic shock: a randomised controlled efficacy trial. JAMA 282:1857–1864 [CrossRef]
     [Google Scholar]
  56. Stoner H. B., Bullen J. J., Cushnie G. H., Batty I. 1967; Fatal intraperitoneal infection with Clostridium welchii type A in passively immunised guinea-pigs. The effect on vascular permeability. . Br J Exp Pathol 48:309–318
     [Google Scholar]
  57. Sutcliffe M. C., Savage A. M., Alford R. H. 1980; Transferrin-dependent growth inhibition of yeast-phase Histoplasma capsulatum by human serum and lymph. J Infect Dis 142:209–219 [CrossRef]
     [Google Scholar]
  58. Tacket C. O., Brenner F., Blake P. A. 1984; Clinical features and an epidemiological study of Vibrio vulnificus infections. J Infect Dis 149:558–561 [CrossRef]
     [Google Scholar]
  59. Taylor R. W., Manganaro L., O'Brien J., Trottier S. J., Parkar N., Veremakis C. 2002; Impact of allogenic packed red blood cell transfusions on nosocomial infection rates in the critically ill patient. Crit Care Med 30:2249–2254 [CrossRef]
     [Google Scholar]
  60. Uchida T., Yamagiwa A., Nakamura K. 1991; The effect of interleukin-1 on iron metabolism in rats. Eur J Haematol 46:1–5
     [Google Scholar]
  61. van Heyningen W. E. 1955; The role of toxins in pathology. In Mechanisms of Microbial Pathogenicity (Society for General Microbiology Symposium no 5 pp  17–39 Edited by Howie J. W., O'Hea A. J. Cambridge: Cambridge University Press;
     [Google Scholar]
  62. Vincent J.-L., Chierego M., Struelens M., Byl B. 2004; Infection control in the intensive care unit. Expert Rev Anti Infect Ther 2:795–805 [CrossRef]
     [Google Scholar]
  63. Wang C., Schwaitzberg S., Berliner E., Zarin D. A., Lau J. 2003; Hyperbaric oxygen for treating wounds, a systematic review of the literature. Arch Surg 138:272–279 [CrossRef]
     [Google Scholar]
  64. Ward C. G., Bullen J. J. 1999; Clinical and physiological aspects. In Iron and Infection. Molecular, Physiological and Clinical Aspects , 2nd edn. pp  369–450 Edited by Bullen J. J, Griffiths E. Chichester: Wiley;
     [Google Scholar]
http://instance.metastore.ingenta.com/content/journal/jmm/10.1099/jmm.0.46386-0
Loading

Most cited Most Cited RSS feed

This is a required field
Please enter a valid email address
Approval was a Success
Invalid data
An Error Occurred
Approval was partially successful, following selected items could not be processed due to error